tm logo
PREDICTSCRIPT
Live/Pending
SU - NON-FINAL ACTION - MAILED

non

on 15 Oct 2024

Last Applicant/ Owned by

46701 Commerce Center Drive

Plymouth

MI

48170

Serial Number

97091070 filed on 25th Oct 2021

Registration Number

N/A

Correspondent Address

ROGER H. BORA

ROGER H. BORA THOMPSON HINE LLP

DAYTON, OH 45342-4934

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

PREDICTSCRIPT

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing


First Use Date in General

31st Jan 2023

First Use Date in Commerce

31st Jan 2023

Mark Details


Serial Number

No 97091070

Mark Type

No Service Mark

Attorney Docket Number

No 101369-004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Oct 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
15th Oct 2024NON-FINAL ACTION E-MAILED
15th Oct 2024SU - NON-FINAL ACTION - WRITTEN
15th Jun 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
15th Jun 2024STATEMENT OF USE PROCESSING COMPLETE
13th May 2024TEAS STATEMENT OF USE RECEIVED
13th May 2024USE AMENDMENT FILED
11th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10th May 2024SOU EXTENSION 1 GRANTED
10th May 2024SOU EXTENSION 1 FILED